-
公开(公告)号:US20170267716A1
公开(公告)日:2017-09-21
申请号:US15071210
申请日:2016-03-16
Applicant: General Electric Company
Inventor: Anthony John Murray , Andrew David Pris , Erik Leeming Kvam , Nandini Nagraj , Eugene Pauling Boden , Ernest William Kovacs , Louisa Ruth Carr , Rui Chen , Tiberiu Mircea Siclovan , Kelly Scott Chichak
IPC: C07K1/36 , C07K16/00 , C12N9/74 , C12N15/115 , C07K14/705
CPC classification number: C07K1/36 , C07K1/32 , C07K14/70564 , C07K16/4291 , C12N9/6429 , C12Y304/21005
Abstract: Provided herein are aptamer-polymer conjugates which are responsive to environmental stimuli and are useful in selective purification of untagged target polypeptides.
-
公开(公告)号:US09040019B2
公开(公告)日:2015-05-26
申请号:US13689819
申请日:2012-11-30
Applicant: General Electric Company
Inventor: Tiberiu Mircea Siclovan , Cristina Abucay Tan Hehir , Rong Zhang , Victoria Eugenia Cotero , Anshika Bajaj
CPC classification number: A61K49/0021 , A61K49/0002 , G01N33/6893 , G01N2800/285
Abstract: A method and a kit for detecting myelin basic protein are provided. The method comprises administering an agent, which binds to myelin basic protein (MBP), to a subject at risk of or diagnosed with a myelin-associated neuropathy, and determining myelination by detecting the agent resided in the subject. The amount of the agent present in the subject is indicative of a myelin-associated neuropathy. A method of quantifying an amount of MBP present in a tissue sample is also provided, wherein the method comprises contacting the tissue sample with the same agent, detecting the agent present in the tissue sample; and quantifying an amount of the agent present in the tissue sample.
Abstract translation: 提供了一种用于检测髓磷脂碱性蛋白的方法和试剂盒。 该方法包括将与髓磷脂碱性蛋白(MBP)结合的药剂施用于患有髓鞘相关性神经病的风险的受试者,并通过检测存在于受试者中的药物来确定髓鞘形成。 存在于受试者中的药剂的量指示髓鞘相关神经病变。 还提供了定量存在于组织样品中的MBP量的方法,其中所述方法包括使组织样品与相同的试剂接触,检测组织样品中存在的试剂; 并定量存在于组织样品中的试剂的量。
-
公开(公告)号:US20140154178A1
公开(公告)日:2014-06-05
申请号:US13689819
申请日:2012-11-30
Applicant: GENERAL ELECTRIC COMPANY
Inventor: Tiberiu Mircea Siclovan , Cristina Abucay Tan Hehir , Rong Zhang , Victoria Eugenia Cotero , Anshika Bajaj
CPC classification number: A61K49/0021 , A61K49/0002 , G01N33/6893 , G01N2800/285
Abstract: A method and a kit for detecting myelin basic protein are provided. The method comprises administering an agent, which binds to myelin basic protein (MBP), to a subject at risk of or diagnosed with a myelin-associated neuropathy, and determining myelination by detecting the agent resided in the subject. The amount of the agent present in the subject is indicative of a myelin-associated neuropathy. A method of quantifying an amount of MBP present in a tissue sample is also provided, wherein the method comprises contacting the tissue sample with the same agent, detecting the agent present in the tissue sample; and quantifying an amount of the agent present in the tissue sample.
Abstract translation: 提供了一种用于检测髓磷脂碱性蛋白的方法和试剂盒。 该方法包括将与髓磷脂碱性蛋白(MBP)结合的药剂施用于患有髓鞘相关性神经病的风险的受试者,并通过检测存在于受试者中的药物来确定髓鞘形成。 存在于受试者中的药剂的量指示髓鞘相关神经病变。 还提供了定量存在于组织样品中的MBP量的方法,其中所述方法包括使组织样品与相同的试剂接触,检测组织样品中存在的试剂; 并定量存在于组织样品中的试剂的量。
-
公开(公告)号:US20170258941A1
公开(公告)日:2017-09-14
申请号:US15069198
申请日:2016-03-14
Applicant: GENERAL ELECTRIC COMPANY
Abstract: The present invention relates to a topical agent that binds specifically to myelin basic protein and its method of use and determining myelination in the subject by detecting the agent present in the subject. A kit containing the agent or its derivatives for use in detecting myelin basic protein is also provided.
-
公开(公告)号:US20230364269A1
公开(公告)日:2023-11-16
申请号:US18350268
申请日:2023-07-11
Applicant: General Electric Company
CPC classification number: A61K49/0021 , A61K9/0014 , A61K47/22 , A61K47/32 , A61K49/0071 , A61B5/0071 , A61B5/0084 , A61K47/10 , A61B5/0068
Abstract: The present invention relates to a topical agent that binds specifically to myelin basic protein and its method of use and determining myelination in the subject by detecting the agent present in the subject. A kit containing the agent or its derivatives for use in detecting myelin basic protein is also provided.
-
公开(公告)号:US20160035448A1
公开(公告)日:2016-02-04
申请号:US14448943
申请日:2014-07-31
Applicant: GENERAL ELECTRIC COMPANY
Inventor: Tiberiu Mircea Siclovan , Peter Andras Zavodszky
IPC: G21G1/00
CPC classification number: G21G1/001 , G21G1/10 , G21G2001/0094
Abstract: The present disclosure relates to the generation of radioisotopes, includes 11-carbon, from liquid targets. In certain embodiments, a liquid hydrazine target is employed which, when irradiated, such as with a charged particle beam, generates 11-carbon in a form that may be recovered and used in downstream processes, such as the generation of radiopharmaceuticals.
Abstract translation: 本公开涉及从液体靶产生放射性同位素,包括11-碳。 在某些实施方案中,使用液体肼靶,当照射时,例如用带电粒子束,可以以可以回收并用于下游工艺(例如放射性药物的生成)的形式产生11碳。
-
公开(公告)号:US11730830B2
公开(公告)日:2023-08-22
申请号:US16994127
申请日:2020-08-14
Applicant: General Electric Company
CPC classification number: A61K49/0021 , A61B5/0068 , A61B5/0071 , A61B5/0084 , A61K9/0014 , A61K47/10 , A61K47/22 , A61K47/32 , A61K49/0071
Abstract: The present invention relates to a topical agent that binds specifically to myelin basic protein and its method of use and determining myelination in the subject by detecting the agent present in the subject. A kit containing the agent or its derivatives for use in detecting myelin basic protein is also provided.
-
公开(公告)号:US20210015946A1
公开(公告)日:2021-01-21
申请号:US16994127
申请日:2020-08-14
Applicant: General Electric Company
Abstract: The present invention relates to a topical agent that binds specifically to myelin basic protein and its method of use and determining myelination in the subject by detecting the agent present in the subject. A kit containing the agent or its derivatives for use in detecting myelin basic protein is also provided.
-
公开(公告)号:US10744212B2
公开(公告)日:2020-08-18
申请号:US15069198
申请日:2016-03-14
Applicant: GENERAL ELECTRIC COMPANY
Abstract: The present invention relates to a topical agent that binds specifically to myelin basic protein and its method of use and determining myelination in the subject by detecting the agent present in the subject. A kit containing the agent or its derivatives for use in detecting myelin basic protein is also provided.
-
-
-
-
-
-
-
-